{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:30:32Z","timestamp":1740133832508,"version":"3.37.3"},"reference-count":18,"publisher":"BMJ","issue":"4","funder":[{"name":"Brazilian Council","award":["486201\/2013-9"],"award-info":[{"award-number":["486201\/2013-9"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To verify the rate and predictors of \u2018quantity not sufficient\u2019 (QNS) among Brazilian infants younger than 3\u2009months with positive newborn screening (NBS) for cystic fibrosis (CF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective, population-based study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Public Statewide Newborn Screening Programme where the incidence rate of CF is \u22481:11\u2009000.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>Subjects with positive two-tiered immunoreactive trypsinogen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Sweat induction and collection were performed in the same facility; one sweat sample was obtained per individual.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>The QNS rate and its predictors; analysis corresponded to the day of sweat collection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 975 participants, QNS rates for 10 and 15\u2009\u00b5L were 3.6% (95% CI 2.5% to 4.9%) and 8.3% (95% CI 6.6% to 10.2%). Infants weighing &gt;3056\u2009and &gt;3845\u2009g and with gestational age higher than 37 weeks had a greater likelihood (5.5 and 6.7, and 2.7 and 5.8 times more, respectively) of avoiding QNS than their peers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>QNS rates fulfilled the requirements, but predictors differed from those recommended by the Cystic Fibrosis Foundations guidelines.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2023-326487","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T18:20:13Z","timestamp":1705947613000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Rate and predictors of insufficient sweat volume in very young infants after pilocarpine gel iontophoresis: prospective, population-based study"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-291X","authenticated-orcid":false,"given":"Paulo","family":"Camargos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Marcos","family":"Bedran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Gon\u00e7alves","family":"Alvim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ol\u00edvia Gon\u00e7alves","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"2024110504400693000_109.4.304.1","doi-asserted-by":"crossref","DOI":"10.3390\/ijns9030041","article-title":"Comparison between Gibson\u2013Cooke and Macroduct methods in the cystic fibrosis neonatal screening program and in subjects who are cystic fibrosis screen-positive with an inconclusive diagnosis","volume":"9","author":"Dolce","year":"2023","journal-title":"Int J Neonatal Screen"},{"key":"2024110504400693000_109.4.304.2","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.649904","article-title":"Sweat testing and recent advances","volume":"9","author":"Gokdemir","year":"2021","journal-title":"Front Pediatr"},{"key":"2024110504400693000_109.4.304.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.03.002"},{"key":"2024110504400693000_109.4.304.4","first-page":"115","article-title":"Australasian guideline (2nd edition): an annex to the CLSI and UK guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis","volume":"38","author":"Massie","year":"2017","journal-title":"Clin Biochem Rev"},{"key":"2024110504400693000_109.4.304.5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024110504400693000_109.4.304.6","unstructured":"Wescor . Macroduct sweat testing system. Available: https:\/\/pdf.medicalexpo.com\/pdf\/elitech-group\/sweat-chek-analyzer\/68339-81683.htmicroliters [Accessed 20 Aug 2023]."},{"key":"2024110504400693000_109.4.304.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.07.053"},{"key":"2024110504400693000_109.4.304.8","doi-asserted-by":"crossref","first-page":"2333794X14553625","DOI":"10.1177\/2333794X14553625","article-title":"Improving the rate of sufficient sweat collected in infants referred for sweat testing in Michigan","volume":"1","author":"Abdulhamid","year":"2014","journal-title":"Glob Pediatr Health"},{"key":"2024110504400693000_109.4.304.9","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.164715"},{"key":"2024110504400693000_109.4.304.10","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPLHG2BUVBT5LY"},{"key":"2024110504400693000_109.4.304.11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcf.2023.04.018","article-title":"Variability of the sweat test in children with cystic fibrosis previously CRMS\/CFSPID: a retrospective monocenter experience","volume":"22","author":"Terlizzi","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2024110504400693000_109.4.304.12","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21318"},{"key":"2024110504400693000_109.4.304.13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.5858\/arpa.2013-0041-OA","article-title":"Implementation of a quality improvement program to improve sweat test performance in a pediatric hospital","volume":"138","author":"Aqil","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"2024110504400693000_109.4.304.14","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21608"},{"key":"2024110504400693000_109.4.304.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"2024110504400693000_109.4.304.16","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2022-324723"},{"key":"2024110504400693000_109.4.304.17","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2023-325629"},{"key":"2024110504400693000_109.4.304.18","first-page":"1","article-title":"Newborn screening for cystic fibrosis: infant and laboratory factors affecting successful sweat test completion","volume":"7","author":"Shenoy","year":"2021","journal-title":"IJNS"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-326487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:40:32Z","timestamp":1730810432000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-326487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,3,19]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/archdischild-2023-326487"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-326487","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"type":"print","value":"0003-9888"},{"type":"electronic","value":"1468-2044"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}